Pharmacokinetics, protein‐binding‐adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment‐naïve HIV‐infected patients

Lambert‐Niclot, S ; Machouf, N ; Peytavin, G ; Soulie, C ; Wirden, M ; Simon, A ; Murphy, RL ; Katlama, C ; Thomas, R ; Calvez, V ; Marcelin, A‐G

HIV medicine, 2010-11, Vol.11 (10), p.666-669 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível